Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis
eLife · 09.05.2023 · 12
DOI: 10.7554/elife.85307 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 09.05.2023. Verfasst von Edwin Ardiansyah und 26 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, Bandung, Indonesia. Hauptthemen laut MEDLINE: Tuberculosis, Meningeal, Meningitis, Cryptococcal, HIV Infections. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Wellcome Trust, NIAID NIH HHS.
Abstract (Originalsprache)
Background
Cellular metabolism is critical for the host immune function against pathogens, and metabolomic analysis may help understand the characteristic immunopathology of tuberculosis. We performed targeted metabolomic analyses in a large cohort of patients with tuberculous meningitis (TBM), the most severe manifestation of tuberculosis, focusing on tryptophan metabolism.
Methods
We studied 1069 Indonesian and Vietnamese adults with TBM (26.6% HIV-positive), 54 non-infectious controls, 50 with bacterial meningitis, and 60 with cryptococcal meningitis. Tryptophan and downstream metabolites were measured in cerebrospinal fluid (CSF) and plasma using targeted liquid chromatography–mass spectrometry. Individual metabolite levels were associated with survival, clinical parameters, CSF bacterial load and 92 CSF inflammatory proteins.
Results
CSF tryptophan was associated with 60-day mortality from TBM (hazard ratio [HR] = 1.16, 95% confidence interval [CI] = 1.10–1.24, for each doubling in CSF tryptophan) both in HIV-negative and -positive patients. CSF tryptophan concentrations did not correlate with CSF bacterial load nor CSF inflammation but were negatively correlated with CSF interferon-gamma concentrations. Unlike tryptophan, CSF concentrations of an intercorrelating cluster of downstream kynurenine metabolites did not predict mortality. These CSF kynurenine metabolites did however correlate with CSF inflammation and markers of blood–CSF leakage, and plasma kynurenine predicted death (HR 1.54, 95% CI = 1.22–1.93). These findings were mostly specific for TBM, although high CSF tryptophan was also associated with mortality from cryptococcal meningitis.
Conclusions
TBM patients with a high baseline CSF tryptophan or high systemic (plasma) kynurenine are at increased risk of death. These findings may reveal new targets for host-directed therapy. Funding: This study was supported by National Institutes of Health (R01AI145781) and the Wellcome Trust (110179/Z/15/Z and 206724/Z/17/Z).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Care and Control of Infectious Diseases, Universitas Padjadjaran, Bandung, Indonesia.
- Department of Internal Medicine and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, Netherlands.
- The Broad Institute of MIT and Harvard, Cambridge, United States.
- Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.
- Department of Neurology, Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
- Department of Internal Medicine, Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
ORCID-Profile: Edwin Ardiansyah, Le Thanh Hoang Nhat, Sofiati Dian, Hoang Thanh Hai, Mihai G Netea, Valerie A C M Koeken, Guy Thwaites, Arjan van Laarhoven, Nguyen Thuy Thuong Thuong
Förderung
- NIDDK NIH HHS
- Wellcome Trust
- NIAID NIH HHS
- National Institutes of Health
- Direktorat Jenderal Pendidikan Tinggi
- Ministry of Research, Technology and Higher Education of the Republic of Indonesia
- United States Agency for International Development
Zitieren
APA
Ardiansyah, E., Avila-Pacheco, J., Nhat, L. T. H., Dian, S., Vinh, D. N., Hai, H. T., Bullock, K., Alisjahbana, B., Netea, M. G., Estiasari, R., Tram, T. T. B., Donovan, J., Heemskerk, D., Chau, T. T. H., Bang, N. D., Ganiem, A. R., Ruslami, R., Koeken, V. A. C. M., Hamers, R. L., …, & Thuong, N. T. T. (2023). Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis. eLife, 12. https://doi.org/10.7554/elife.85307
Vancouver
Ardiansyah E, Avila-Pacheco J, Nhat LTH, Dian S, Vinh DN, Hai HT, et al. Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis. eLife. 2023;12. doi:10.7554/elife.85307
BibTeX
@article{Ardiansyah2023,
author = {Ardiansyah, Edwin and Avila-Pacheco, Julian and Nhat, Le Thanh Hoang and Dian, Sofiati and Vinh, Dao Nguyen and Hai, Hoang Thanh and Bullock, Kevin and Alisjahbana, Bachti and Netea, Mihai G and Estiasari, Riwanti and Tram, Trinh Thi Bich and Donovan, Joseph and Heemskerk, Dorothee and Chau, Tran Thi Hong and Bang, Nguyen Duc and Ganiem, Ahmad Rizal and Ruslami, Rovina and Koeken, Valerie A C M and Hamers, Raph L and Imran, Darma and Maharani, Kartika and Kumar, Vinod and Clish, Clary B and van Crevel, Reinout and Thwaites, Guy and van Laarhoven, Arjan and Thuong, Nguyen Thuy Thuong},
title = {Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.85307}
}
EUVIMED